Latest Headlines
- 
                    Prinses Máxima Center For Pediatric Oncology Implements Callisto™ From Volta Labs To Streamline Clinical Genomics Workflows
                        9/10/2025
                    
Volta Labs today announced that the Prinses Máxima Center for Pediatric Oncology has acquired the Callisto™ platform to streamline sample preparation across multiple genomics workflows, supporting both Illumina and Oxford Nanopore Technologies (ONT) sequencing platforms.
 - 
                    Exact Sciences Launches Cancerguard™, First-Of-Its-Kind Multi-Cancer Early Detection Blood Test
                        9/10/2025
                    
Exact Sciences Corp. a leader in cancer diagnostics, today announced the launch of the Cancerguard test, a new multi-cancer early detection (MCED) blood test that is now available as a laboratory-developed test (LDT) in the United States.
 - 
                    OptraSCAN To Introduce HER2 Scan + Analyze Pilot At CAP 2025
                        9/9/2025
                    
OptraSCAN, a leader in digital pathology and AI-powered diagnostics, today announced the launch of its HER2 Scan + Analyze Quantitative Solution Pilot Program at the College of American Pathologists (CAP) 2025 - The Pathologists’ Meeting, running September 13-16 in Orlando, Florida.
 - 
                    Sapio Sciences And Ultima Genomics Partner To Advance Multi-Omics Research
                        9/9/2025
                    
Sapio Sciences, the science-aware lab informatics platform, today announced a strategic partnership with Ultima Genomics.
 - 
                    Henry Schein Medical Expands SolutionsHub With Colaborate
                        9/9/2025
                    
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., has expanded its SolutionsHub™ with the addition of Colaborate, a full-service management consulting firm dedicated to serving independent and hospital-based medical laboratories.
 - 
                    Panome Bio Advances Clinical Discovery With First Metabolomics Workflow For Formalin-Fixed Paraffin-Embedded (FFPE) Samples
                        9/9/2025
                    
Panome Bio, a leading provider of multi-omic services, announced a first of its kind commercial offering applying their leading discovery metabolomics capabilities to Formalin-Fixed Paraffin-Embedded (FFPE) samples.
 - 
                    Philips Announces Digital Pathology Scanner With Native, Configurable DICOM JPEG And JPEG XL Output In World First
                        9/8/2025
                    
Pathology plays a crucial role in the diagnosis of a variety of diseases, particularly cancer, through examination of patient tissue samples.
 - 
                    Roche Receives CE IVDR Approval For HER2 (4B5) Companion Diagnostic Test To Identify HER2-Ultralow Breast Cancer And Biliary Tract Cancer Patients
                        9/5/2025
                    
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today it has received CE IVDR approval for two label expansions for its VENTANA® HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx* assay.
 - 
                    GeodAIsics And HORIBA Partner To Develop AI-Powered Sepsis Detection Solution
                        9/4/2025
                    
GeodAIsics, an AI-driven healthcare startup, and HORIBA ABX SAS, one of the group companies of HORIBA, a leader in measurement and test solutions for applications across various business fields, have announced a strategic partnership to develop an GenAI-powered software solution for early sepsis detection.
 - 
                    diaago Expands Automation Offering Through Partnership With PAA, Introducing The KX-2 Collaborative Robot
                        9/4/2025
                    
diaago, a stocking distributor of laboratory consumables and equipment, has added innovations from Peak Analysis & Automation (PAA) to its automation portfolio, marking another strategic partnership to support the growing need for versatile automation solutions.